Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amphotericin B methyl ester peptide derivative and preparation method thereof

A technology of derivatives and methyl groups, applied in the field of amphotericin B methyl esterified peptide derivatives and their synthesis and preparation, can solve the problems of liposome instability, increased therapeutic dose, and high cost

Pending Publication Date: 2021-07-16
SHANGHAI INST OF PHARMA IND +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But amphotericin B liposome preparation also has the following disadvantages: one, the antibacterial activity of liposome preparation is worse than amphotericin B, need to increase the therapeutic dose, two, liposome preparation cost is higher , the price is relatively expensive, three, the instability of liposome itself, four, liposome preparations have not fundamentally eliminated the toxic side effects such as nephrotoxicity of amphotericin B

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amphotericin B methyl ester peptide derivative and preparation method thereof
  • Amphotericin B methyl ester peptide derivative and preparation method thereof
  • Amphotericin B methyl ester peptide derivative and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0181] Example 1: Preparation and purification of DMR005-JZH

[0182] Hydrophilic peptide structure: Fmoc-AEEAc-AEEAc-AEEAc-AEEAc–AEEAc-OH

[0183] DMR005-JZH structure:

[0184]

[0185] (1) Materials and reagents

[0186] 2-CTC resin, substitution value 0.945mmol / g.

[0187] The amino acid is: Fmoc-AEEAc-OH

[0188] Synthetic reagents: HATU, DMF, DCM, DIEA, piperidine, methyl iodide.

[0189] (2) Instrument

[0190] CS-BIO peptide synthesizer, Waters600 semi-preparative high performance liquid chromatography, Beckman centrifuge, Buchi rotary evaporator.

[0191] (3) Operation steps (take 1g resin as an example)

[0192] a. Solid-phase chemical synthesis of peptides

[0193] Weigh 1.00g of 2-CTC resin, put it in the reactor of polypeptide synthesizer, add 10mL DCM, soak for 1h, weigh 2-3 times the amount of Fmoc-AEEAc-OH and absorb 4-6 times the amount of DIEA and add 10mL DCM to dissolve it , put it into the reactor, and carry out the reaction. The reaction temper...

Embodiment 2

[0218] Example 2: Preparation and purification of DMR078-JZH

[0219] Hydrophilic peptide structure: Fmoc-AEEAc-Gly-AEEAc-Gly–AEEAc-OH

[0220] DMR078-JZH structure:

[0221]

[0222] (1) Materials and reagents

[0223] 2-CTC resin, substitution value 0.945mmol / g.

[0224] The amino acids are: Fmoc-AEEAc-OH and Fmoc-Gly-OH

[0225] Synthetic reagents: HATU, DMF, DCM, DIE, piperidine, methyl iodide.

[0226] (2) Instrument

[0227] CS-BIO peptide synthesizer, Waters600 semi-preparative high performance liquid chromatography, Beckman centrifuge, Buchi rotary evaporator.

[0228] (3) Operation steps (take 1g resin as an example)

[0229] a. Solid-phase chemical synthesis of peptides

[0230] Weigh 1.00g of 2-CTC resin, put it in the reactor of polypeptide synthesizer, add 10mL DCM, soak for 1h, weigh 2-3 times the amount of Fmoc-AEEAc-OH and absorb 4-6 times the amount of DIEA and add 10mL DCM to dissolve it , put it into the reactor, and carry out the reaction. The re...

Embodiment 3

[0256] Example 3: Preparation and purification of DMR086

[0257] Hydrophilic peptide structure: Fmoc-AEEAc-AEEAc-OH

[0258] DMR086 structure:

[0259]

[0260] (1) Materials and reagents

[0261] 2-CTC resin, substitution value 0.945mmol / g.

[0262] Amino acid: Fmoc-AEEAc-OH,

[0263] Synthetic reagents: HATU, DMF, DCM, DIEA, piperidine, methyl iodide.

[0264] (2) Instrument

[0265] CS-BIO peptide synthesizer, Waters600 semi-preparative high performance liquid chromatography, Beckman centrifuge, Buchi rotary evaporator.

[0266] (3) Operation steps (take 1g resin as an example)

[0267] a. Solid-phase chemical synthesis of peptides

[0268]Weigh 1.00g of 2-CTC resin, place it in a polypeptide synthesizer reactor, add 10mL DCM, soak for 1h, weigh 2-3 times the amount of Fmoc-AEEA-OH and absorb 4-6 times the amount of DIEA and add 10mL DCM After dissolving, put it into the reactor and carry out the reaction. The reaction temperature is room temperature (25°C and a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, and particularly relates to an amphotericin B methyl ester peptide derivative and a preparation method thereof. The amphotericin B peptide derivative disclosed by the invention has a broad-spectrum and efficient bactericidal effect on drug-resistant bacteria and fungi.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to the modification of amphotericin B methyl esterified peptide derivatives and its preparation method and application, specifically to a series of amphotericin with high solubility, low toxicity and good antibacterial activity Peptide derivatives of methylated peptide B and their synthesis, preparation and application. Background technique [0002] Amphotericin B (AMB) is a polyene broad-spectrum antifungal drug, suitable for the treatment of the following fungal infections: Candidiasis, Cryptococcosis, Blastomycosis ), Coccidioidomycosis, mucormycosis caused by Mucor, Sporotrichosis caused by Sporothrix, caused by most Aspergillus ) caused by aspergillosis (aspergillosis), etc. [0003] Amphotericin B has attracted much attention since its isolation in 1955 from a Streptomyces metabolite. On the one hand, amphotericin B is the gold standard in the clinical treatment of deep fungal infecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H17/08C07H1/00A61K31/7048A61P31/10
CPCA61P31/10C07H1/00C07H17/08Y02P20/55
Inventor 冯军东圆珍张喜全张金华赵文杰徐宏江
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products